Overall survival outcomes in MATTERHORN trial support perioperative durvalumab plus chemotherapy as standard of care.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/durvalumab-plus-flot-ups-survival-early-upper-gi-cancer-2025a1000sar?src=rss
Author :
Publish date : 2025-10-18 16:41:00
Copyright for syndicated content belongs to the linked Source.
